Skip to product information
1 of 1

GeneBio Systems

UHRF2 Polyclonal Antibody

UHRF2 Polyclonal Antibody

SKU:E-AB-13450

Regular price €491,95 EUR
Regular price Sale price €491,95 EUR
Sale Sold out
Shipping calculated at checkout.

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Polyclonal Antibodies

Abbreviation: UHRF2

Target Synonym: DKFZp434B0920;DKFZp686G0837;E3 ubiquitin-protein ligase UHRF2;MGC33463;Np95 like RING finger protein;Np95-like ring finger protein;Np95/ICBP90 like RING finger protein;Np95/ICBP90-like RING finger protein;Nuclear protein 97;Nuclear zinc finger protein Np97;RING finger protein 107;RNF 107;RP11-472F14.2;Ubiquitin like containing PHD and RING finger domains protein 2;Ubiquitin-like PHD and RING finger domain-containing protein 2;Ubiquitin-like-containing PHD and RING finger domains protein 2;Uhrf2;UHRF2;URF 2

Research Areas: Cancer;Cell Biology

Conjugation: Unconjugated

Host: Rabbit

Species reactivity: Human;Mouse

Application: IHC

Isotype: IgG

Clonality: Polyclonal

Clone NO.:

UNIProt ID: Q96PU4

Accession:

Background: This gene encodes a nuclear protein which is involved in cell-cycle regulation. The encoded protein is a ubiquitin-ligase capable of ubiquinating PCNP (PEST-containing nuclear protein), and together they may play a role in tumorigenesis. The encoded protein contains an NIRF_N domain, a PHD finger, a set- and ring-associated (SRA) domain, and a RING finger domain and several of these domains have been shown to be essential for the regulation of cell proliferation. This protein may also have a role in intranuclear degradation of polyglutamine aggregates. Alternative splicing results in multiple transcript variants some of which are non-protein coding.

Concentration: 0.8 mg/mL

Immunogen: Synthetic peptide of human UHRF2

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Purification method: Affinity purification

Dilution: IHC 1:50-1:200

Calculated MW:

ObservedMW:

View full details